Human intestinal bitter taste receptors regulate innate immune responses and metabolic regulators in obesity.

J Clin Invest · 2022 · PMC8803326 · PMID 34784295

Europe PMC DOI

hedged sentences

0.0600

closest p · 1.2× alpha

0.1000

boldest claim

The sentences

showed a trendP = 0.06so close (0.05 < p ≤ 0.1)

Arglabin-CSN showed a trend ( P = 0.06) toward reducing E . coli growth compared with Krebs-CSN, but it was not significantly different from the reduction induced by the bacteriostatic control.

also in 53,322 other papers

a weak trendP < 0.1so close (0.05 < p ≤ 0.1)

In contrast, in samples from less sensitive TAS2R43 + S patients (36%, n = 5–6), aloin-CSN showed only a weak trend ( P < 0.1) for an increase, and in the TAS2R43 – group (21%, n = 3–4), we observed no effect at all.

also in 1,404 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.